Detalhe da pesquisa
1.
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Int J Cancer
; 153(5): 1026-1034, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246577
2.
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
Int J Cancer
; 147(11): 3152-3159, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32391579
3.
DFMO inhibition of neuroblastoma tumorigenesis.
Cancer Med
; 13(9): e7207, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686627
4.
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
J Clin Oncol
; 42(1): 90-102, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883734
5.
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Cancer Rep (Hoboken)
; 5(11): e1616, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35355452
6.
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma.
J Pediatr Hematol Oncol
; 33(1): 25-30, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21063221
7.
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Cancer Res
; 81(23): 5818-5832, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610968
8.
Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo.
J Pediatr Hematol Oncol
; 31(3): 187-93, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19262245
9.
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
Cancer Med
; 4(6): 871-86, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25720842
10.
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
PLoS One
; 10(5): e0127246, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018967
11.
Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma.
Int J Oncol
; 38(5): 1329-41, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21399873
12.
Antitumor activity of nifurtimox observed in a patient with neuroblastoma.
J Pediatr Hematol Oncol
; 28(10): 693-5, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17023833